Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 USD | -3.26% | -0.56% | -11.88% |
Mar. 13 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.88% | 45.18M | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-21.94% | 28.08B | |
+53.11% | 24.72B | |
-5.41% | 17.47B | |
-44.23% | 11.69B | |
-17.60% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- AADI Stock
- News Aadi Bioscience, Inc.
- Aadi Bioscience's Fyarro Gets FDA Approval to Treat Certain Cell Tumor Patients; Shares Climb